Hydromorphone Hydrochloride Suppository — FDA Drug Shortage
The FDA lists a drug shortage record for Hydromorphone Hydrochloride Suppository (suppository) from Padagis US LLC with status To Be Discontinued. The shortage was first posted on 07/23/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Padagis US LLC
- Package NDC
- 0574-7224-06
- Dosage Form
- Suppository
- Presentation
- Hydromorphone Hydrochloride, Suppository, 3 mg (NDC 0574-7224-06)
- Initial Posting
- 07/23/2026
- Revised Date